JP3345401B2 - 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析 - Google Patents
複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析Info
- Publication number
- JP3345401B2 JP3345401B2 JP2000566460A JP2000566460A JP3345401B2 JP 3345401 B2 JP3345401 B2 JP 3345401B2 JP 2000566460 A JP2000566460 A JP 2000566460A JP 2000566460 A JP2000566460 A JP 2000566460A JP 3345401 B2 JP3345401 B2 JP 3345401B2
- Authority
- JP
- Japan
- Prior art keywords
- protein
- affinity
- reagent
- group
- tagged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 305
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 288
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 230000004853 protein function Effects 0.000 title claims abstract description 20
- 238000004445 quantitative analysis Methods 0.000 title abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 203
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 177
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 160
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 83
- 125000005647 linker group Chemical group 0.000 claims abstract description 78
- 238000006243 chemical reaction Methods 0.000 claims abstract description 61
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 60
- 230000014509 gene expression Effects 0.000 claims abstract description 31
- 239000007801 affinity label Substances 0.000 claims abstract description 28
- 238000002372 labelling Methods 0.000 claims abstract description 14
- 239000012070 reactive reagent Substances 0.000 claims abstract description 13
- 102000004190 Enzymes Human genes 0.000 claims description 99
- 108090000790 Enzymes Proteins 0.000 claims description 99
- 239000000758 substrate Substances 0.000 claims description 90
- 210000004027 cell Anatomy 0.000 claims description 81
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 56
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 48
- 150000002500 ions Chemical class 0.000 claims description 40
- 108010052285 Membrane Proteins Proteins 0.000 claims description 36
- 102100033949 Basic salivary proline-rich protein 3 Human genes 0.000 claims description 29
- 102000018697 Membrane Proteins Human genes 0.000 claims description 26
- 235000020958 biotin Nutrition 0.000 claims description 23
- 239000011616 biotin Substances 0.000 claims description 22
- 229960002685 biotin Drugs 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 150000002148 esters Chemical class 0.000 claims description 21
- 238000011002 quantification Methods 0.000 claims description 19
- 125000003342 alkenyl group Chemical group 0.000 claims description 17
- 125000003545 alkoxy group Chemical group 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 15
- 230000027455 binding Effects 0.000 claims description 15
- 230000007812 deficiency Effects 0.000 claims description 14
- 230000002255 enzymatic effect Effects 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 125000000304 alkynyl group Chemical group 0.000 claims description 13
- 125000000524 functional group Chemical group 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- 108091006055 affinity-tagged proteins Proteins 0.000 claims description 10
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 10
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 10
- 230000003993 interaction Effects 0.000 claims description 10
- 238000004587 chromatography analysis Methods 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 230000001413 cellular effect Effects 0.000 claims description 8
- QJPWUUJVYOJNMH-VKHMYHEASA-N L-homoserine lactone Chemical compound N[C@H]1CCOC1=O QJPWUUJVYOJNMH-VKHMYHEASA-N 0.000 claims description 7
- 102000035195 Peptidases Human genes 0.000 claims description 6
- 108091005804 Peptidases Proteins 0.000 claims description 6
- 150000001412 amines Chemical group 0.000 claims description 6
- 150000001615 biotins Chemical class 0.000 claims description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 208000032170 Congenital Abnormalities Diseases 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 230000007698 birth defect Effects 0.000 claims description 5
- 239000003550 marker Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 208000015439 Lysosomal storage disease Diseases 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 claims description 4
- OJLSSULCTKBVOB-UHFFFAOYSA-N (2,3,5,6-tetrafluorophenyl) 2,2,2-trifluoroacetate Chemical compound FC1=CC(F)=C(F)C(OC(=O)C(F)(F)F)=C1F OJLSSULCTKBVOB-UHFFFAOYSA-N 0.000 claims description 3
- 150000000180 1,2-diols Chemical class 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- 206010010356 Congenital anomaly Diseases 0.000 claims description 3
- 108010024636 Glutathione Proteins 0.000 claims description 3
- 229920002971 Heparan sulfate Polymers 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- 108010023320 N-acetylglucosamine-6-sulfatase Proteins 0.000 claims description 3
- 102000056067 N-acetylglucosamine-6-sulfatases Human genes 0.000 claims description 3
- 108010006140 N-sulfoglucosamine sulfohydrolase Proteins 0.000 claims description 3
- 102100027661 N-sulphoglucosamine sulphohydrolase Human genes 0.000 claims description 3
- 229910018557 Si O Inorganic materials 0.000 claims description 3
- 150000008065 acid anhydrides Chemical class 0.000 claims description 3
- 150000001504 aryl thiols Chemical class 0.000 claims description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 3
- 230000007613 environmental effect Effects 0.000 claims description 3
- 150000002118 epoxides Chemical class 0.000 claims description 3
- 125000004185 ester group Chemical group 0.000 claims description 3
- 229960003180 glutathione Drugs 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 150000002513 isocyanates Chemical class 0.000 claims description 3
- 150000002540 isothiocyanates Chemical class 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 150000002825 nitriles Chemical class 0.000 claims description 3
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 claims description 3
- 150000003141 primary amines Chemical group 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 claims description 3
- 150000003461 sulfonyl halides Chemical class 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 210000003463 organelle Anatomy 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims 28
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims 2
- 101710202061 N-acetyltransferase Proteins 0.000 claims 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims 2
- 125000002228 disulfide group Chemical group 0.000 claims 2
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical group NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 claims 2
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 claims 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical group OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims 2
- 150000001298 alcohols Chemical class 0.000 claims 1
- 108091005996 glycated proteins Proteins 0.000 claims 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 56
- 239000007795 chemical reaction product Substances 0.000 abstract description 17
- 239000013060 biological fluid Substances 0.000 abstract description 11
- 238000006911 enzymatic reaction Methods 0.000 abstract description 9
- 238000002955 isolation Methods 0.000 abstract description 7
- 230000000155 isotopic effect Effects 0.000 abstract description 6
- 102000007079 Peptide Fragments Human genes 0.000 abstract description 5
- 108010033276 Peptide Fragments Proteins 0.000 abstract description 5
- 230000008859 change Effects 0.000 abstract description 4
- 238000004451 qualitative analysis Methods 0.000 abstract description 2
- 238000006467 substitution reaction Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 211
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 72
- 239000000523 sample Substances 0.000 description 69
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 49
- 238000004458 analytical method Methods 0.000 description 49
- 239000002904 solvent Substances 0.000 description 40
- 239000000243 solution Substances 0.000 description 37
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
- 238000003556 assay Methods 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 230000015572 biosynthetic process Effects 0.000 description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 26
- 239000012071 phase Substances 0.000 description 26
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 25
- -1 ether diamines Chemical class 0.000 description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 238000001228 spectrum Methods 0.000 description 20
- 238000003756 stirring Methods 0.000 description 20
- 238000004007 reversed phase HPLC Methods 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 238000003786 synthesis reaction Methods 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 16
- 238000005119 centrifugation Methods 0.000 description 15
- 238000005516 engineering process Methods 0.000 description 15
- 101001094831 Homo sapiens Phosphomannomutase 2 Proteins 0.000 description 14
- 102100035362 Phosphomannomutase 2 Human genes 0.000 description 14
- 239000012467 final product Substances 0.000 description 14
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 13
- 238000013459 approach Methods 0.000 description 13
- 238000002390 rotary evaporation Methods 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 239000011324 bead Substances 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 12
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 12
- 238000000132 electrospray ionisation Methods 0.000 description 12
- 239000008103 glucose Substances 0.000 description 12
- 238000001514 detection method Methods 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- 239000000377 silicon dioxide Substances 0.000 description 11
- 238000005160 1H NMR spectroscopy Methods 0.000 description 10
- 239000012300 argon atmosphere Substances 0.000 description 10
- 229930182830 galactose Natural products 0.000 description 10
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical group C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 9
- 150000002031 dolichols Chemical class 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 108010026552 Proteome Proteins 0.000 description 8
- 108010090804 Streptavidin Proteins 0.000 description 8
- 102000004142 Trypsin Human genes 0.000 description 8
- 108090000631 Trypsin Proteins 0.000 description 8
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 8
- 238000013467 fragmentation Methods 0.000 description 8
- 238000006062 fragmentation reaction Methods 0.000 description 8
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000012588 trypsin Substances 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 7
- 125000004429 atom Chemical group 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 238000003776 cleavage reaction Methods 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 7
- 235000018417 cysteine Nutrition 0.000 description 7
- 229910052805 deuterium Inorganic materials 0.000 description 7
- 238000005040 ion trap Methods 0.000 description 7
- 239000003446 ligand Substances 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 230000007017 scission Effects 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 108010077895 Sarcosine Proteins 0.000 description 6
- 238000001042 affinity chromatography Methods 0.000 description 6
- 238000007413 biotinylation Methods 0.000 description 6
- 230000006287 biotinylation Effects 0.000 description 6
- 239000013592 cell lysate Substances 0.000 description 6
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 6
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 5
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 5
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 5
- 108090001008 Avidin Proteins 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 5
- 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 5
- 108010044467 Isoenzymes Proteins 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 238000001261 affinity purification Methods 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 150000004985 diamines Chemical group 0.000 description 5
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 230000013595 glycosylation Effects 0.000 description 5
- 238000006206 glycosylation reaction Methods 0.000 description 5
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 5
- 238000001819 mass spectrum Methods 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 108091000115 phosphomannomutase Proteins 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 229940043230 sarcosine Drugs 0.000 description 5
- MVMSCBBUIHUTGJ-UHFFFAOYSA-N 10108-97-1 Natural products C1=2NC(N)=NC(=O)C=2N=CN1C(C(C1O)O)OC1COP(O)(=O)OP(O)(=O)OC1OC(CO)C(O)C(O)C1O MVMSCBBUIHUTGJ-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- MVMSCBBUIHUTGJ-GDJBGNAASA-N GDP-alpha-D-mannose Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=C(NC(=O)C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O MVMSCBBUIHUTGJ-GDJBGNAASA-N 0.000 description 4
- 201000008892 GM1 Gangliosidosis Diseases 0.000 description 4
- 238000006845 Michael addition reaction Methods 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 102000030605 Phosphomannomutase Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- HXXFSFRBOHSIMQ-RWOPYEJCSA-L alpha-D-mannose 1-phosphate(2-) Chemical compound OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-RWOPYEJCSA-L 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 229940068840 d-biotin Drugs 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000001212 derivatisation Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 150000002576 ketones Chemical group 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 210000001589 microsome Anatomy 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 229920000570 polyether Polymers 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 3
- FCDUPOLHSWBTFL-AUTRQRHGSA-N 2-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoyl-methylamino]acetic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)N(CC(O)=O)C)SC[C@@H]21 FCDUPOLHSWBTFL-AUTRQRHGSA-N 0.000 description 3
- JCEZOHLWDIONSP-UHFFFAOYSA-N 3-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propan-1-amine Chemical compound NCCCOCCOCCOCCCN JCEZOHLWDIONSP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
- 101000918297 Caenorhabditis elegans Exostosin-2 homolog Proteins 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 102000004357 Transferases Human genes 0.000 description 3
- 108090000992 Transferases Proteins 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 150000001408 amides Chemical group 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 238000000738 capillary electrophoresis-mass spectrometry Methods 0.000 description 3
- 239000003729 cation exchange resin Substances 0.000 description 3
- 235000000484 citronellol Nutrition 0.000 description 3
- 238000001360 collision-induced dissociation Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 108091005608 glycosylated proteins Proteins 0.000 description 3
- 102000035122 glycosylated proteins Human genes 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 239000013074 reference sample Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000011949 solid catalyst Substances 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 108010051423 streptavidin-agarose Proteins 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229910052723 transition metal Inorganic materials 0.000 description 3
- 150000003624 transition metals Chemical class 0.000 description 3
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- PBLZLIFKVPJDCO-UHFFFAOYSA-N 12-aminododecanoic acid Chemical compound NCCCCCCCCCCCC(O)=O PBLZLIFKVPJDCO-UHFFFAOYSA-N 0.000 description 2
- IDOQDZANRZQBTP-UHFFFAOYSA-N 2-[2-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=CC=C1OCCO IDOQDZANRZQBTP-UHFFFAOYSA-N 0.000 description 2
- XPFHLPUCVACBDX-BNCMJVKFSA-N 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-methyl-2-[2-(methylamino)acetyl]pentanamide Chemical compound CNC(C(CCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)C(CNC)=O)=O XPFHLPUCVACBDX-BNCMJVKFSA-N 0.000 description 2
- GYSGPDASYAXSKQ-AFRWMIOYSA-N 8-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-1-iodo-3-[2-(2-propoxyethoxy)ethoxymethyl]-3-(triaminomethyl)octane-2,4-dione Chemical compound CCCOCCOCCOCC(C(=O)CCCC[C@H]1[C@@H]2[C@H](CS1)NC(=O)N2)(C(=O)CI)C(N)(N)N GYSGPDASYAXSKQ-AFRWMIOYSA-N 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 102100024296 Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Human genes 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 102100031680 Beta-catenin-interacting protein 1 Human genes 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- 101150029707 ERBB2 gene Proteins 0.000 description 2
- 108010058643 Fungal Proteins Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000002268 Hexosaminidases Human genes 0.000 description 2
- 108010000540 Hexosaminidases Proteins 0.000 description 2
- 101000993469 Homo sapiens Beta-catenin-interacting protein 1 Proteins 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 108010038016 Mannose-1-phosphate guanylyltransferase Proteins 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 102000004584 Somatomedin Receptors Human genes 0.000 description 2
- 108010017622 Somatomedin Receptors Proteins 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 229920004929 Triton X-114 Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 108010070113 alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I Proteins 0.000 description 2
- 108010090354 alpha-1,6-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 2
- 108010063086 avidin-agarose Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 125000004431 deuterium atom Chemical group 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical group [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 125000003147 glycosyl group Chemical group 0.000 description 2
- 150000002402 hexoses Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000001114 immunoprecipitation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 230000009822 protein phosphorylation Effects 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 description 2
- 239000003774 sulfhydryl reagent Substances 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 231100000588 tumorigenic Toxicity 0.000 description 2
- 230000000381 tumorigenic effect Effects 0.000 description 2
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 235000021241 α-lactalbumin Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
- RQQZGQHBFZNFTO-KPCOEVGBSA-N (2,3,4,5-tetrafluorophenyl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound FC1=C(F)C(F)=CC(OC(=O)CCCC[C@H]2[C@H]3NC(=O)N[C@H]3CS2)=C1F RQQZGQHBFZNFTO-KPCOEVGBSA-N 0.000 description 1
- FFPGMMMTGGBBLX-BHDSKKPTSA-N (2,3,5,6-tetrafluorophenyl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound FC1=CC(F)=C(F)C(OC(=O)CCCC[C@H]2[C@H]3NC(=O)N[C@H]3CS2)=C1F FFPGMMMTGGBBLX-BHDSKKPTSA-N 0.000 description 1
- RBNSZWOCWHGHMR-UHFFFAOYSA-N (2-iodoacetyl) 2-iodoacetate Chemical compound ICC(=O)OC(=O)CI RBNSZWOCWHGHMR-UHFFFAOYSA-N 0.000 description 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
- RWANFUZQWINQBY-BNDIWNMDSA-N (2r,3s,4s,5s,6r)-2-(hydroxymethyl)-6-(4-isothiocyanatophenoxy)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(N=C=S)C=C1 RWANFUZQWINQBY-BNDIWNMDSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- MIAKOEWBCMPCQR-YBXAARCKSA-N (2s,3r,4s,5r,6r)-2-(4-aminophenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound C1=CC(N)=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MIAKOEWBCMPCQR-YBXAARCKSA-N 0.000 description 1
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- UPYYXURNCZOCAF-UHFFFAOYSA-N 1-chloro-3-[2-[2-(3-chloropropoxy)ethoxy]ethoxy]propane Chemical compound ClCCCOCCOCCOCCCCl UPYYXURNCZOCAF-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- ZNPHXDUIJNNHOA-SKPFHBQLSA-N 12-[[2-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoyl-methylamino]acetyl]amino]dodecanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)N(CC(=O)NCCCCCCCCCCCC(O)=O)C)SC[C@@H]21 ZNPHXDUIJNNHOA-SKPFHBQLSA-N 0.000 description 1
- PBYIIRLNRCVTMQ-UHFFFAOYSA-N 2,3,5,6-tetrafluorophenol Chemical compound OC1=C(F)C(F)=CC(F)=C1F PBYIIRLNRCVTMQ-UHFFFAOYSA-N 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- JUAGNSFMKLTCCT-UHFFFAOYSA-N 2-aminoacetic acid;carbonic acid Chemical compound OC(O)=O.NCC(O)=O JUAGNSFMKLTCCT-UHFFFAOYSA-N 0.000 description 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
- XEICSQLBXZSODE-UHFFFAOYSA-N 3-[2-[2-(2-cyanoethoxy)ethoxy]ethoxy]propanenitrile Chemical compound N#CCCOCCOCCOCCC#N XEICSQLBXZSODE-UHFFFAOYSA-N 0.000 description 1
- NDAWVRBCMMXMME-UHFFFAOYSA-N 3-[2-[2-(3-hydroxypropoxy)ethoxy]ethoxy]propan-1-ol Chemical compound OCCCOCCOCCOCCCO NDAWVRBCMMXMME-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HALBUUKRQSSWHH-UHFFFAOYSA-N 4-[2-[2-(4-aminobutoxy)ethoxy]ethoxy]butan-1-amine Chemical compound NCCCCOCCOCCOCCCCN HALBUUKRQSSWHH-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- JCLFHZLOKITRCE-UHFFFAOYSA-N 4-pentoxyphenol Chemical compound CCCCCOC1=CC=C(O)C=C1 JCLFHZLOKITRCE-UHFFFAOYSA-N 0.000 description 1
- INMFUNAVPJKPPH-QHSNHLGFSA-N 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-2-[2-(methylamino)acetyl]pentanamide Chemical compound CNCC(=O)C(C(=O)N)CCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12 INMFUNAVPJKPPH-QHSNHLGFSA-N 0.000 description 1
- LLIANSAISVOLHR-GBCQHVBFSA-N 5-[(3as,4s,6ar)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical class N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 LLIANSAISVOLHR-GBCQHVBFSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108050001427 Avidin/streptavidin Proteins 0.000 description 1
- 238000009020 BCA Protein Assay Kit Methods 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010039206 Biotinidase Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 108091028026 C-DNA Proteins 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010010099 Combined immunodeficiency Diseases 0.000 description 1
- 208000014567 Congenital Disorders of Glycosylation Diseases 0.000 description 1
- 201000002200 Congenital disorder of glycosylation Diseases 0.000 description 1
- 108700004546 Congenital disorder of glycosylation type 1A Proteins 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 102100023044 Cytosolic acyl coenzyme A thioester hydrolase Human genes 0.000 description 1
- 101710152190 Cytosolic acyl coenzyme A thioester hydrolase Proteins 0.000 description 1
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 1
- NBSCHQHZLSJFNQ-QTVWNMPRSA-N D-Mannose-6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O NBSCHQHZLSJFNQ-QTVWNMPRSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108010089072 Dolichyl-diphosphooligosaccharide-protein glycotransferase Proteins 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical group NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 101150094690 GAL1 gene Proteins 0.000 description 1
- 101150038242 GAL10 gene Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102100028501 Galanin peptides Human genes 0.000 description 1
- 102100024637 Galectin-10 Human genes 0.000 description 1
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
- 208000009796 Gangliosidoses Diseases 0.000 description 1
- 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 102000038455 IGF Type 1 Receptor Human genes 0.000 description 1
- 108010031794 IGF Type 1 Receptor Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 208000028226 Krabbe disease Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 108010022476 N-Ac-CHAVC-NH2 Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241001274216 Naso Species 0.000 description 1
- 208000014060 Niemann-Pick disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- HEMHJVSKTPXQMS-DYCDLGHISA-M Sodium hydroxide-d Chemical compound [Na+].[2H][O-] HEMHJVSKTPXQMS-DYCDLGHISA-M 0.000 description 1
- 108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 description 1
- 102000005262 Sulfatase Human genes 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042971 T-cell lymphoma Diseases 0.000 description 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 101000654530 Tupaia virus (isolate Tupaia/Thailand/-/1986) Small hydrophobic protein Proteins 0.000 description 1
- LFTYTUAZOPRMMI-CFRASDGPSA-N UDP-N-acetyl-alpha-D-glucosamine Chemical compound O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-CFRASDGPSA-N 0.000 description 1
- LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- LEBBDRXHHNYZIA-LDUWYPJVSA-N [(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] n-[(z)-1,3-dihydroxyoctadec-4-en-2-yl]carbamate Chemical compound CCCCCCCCCCCCC\C=C/C(O)C(CO)NC(=O)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O LEBBDRXHHNYZIA-LDUWYPJVSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 102000010126 acid sphingomyelin phosphodiesterase activity proteins Human genes 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 150000001543 aryl boronic acids Chemical class 0.000 description 1
- 238000011717 athymic nude mouse Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical group NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 230000009287 biochemical signal transduction Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- XFLVBMBRLSCJAI-ZKWXMUAHSA-N biotin amide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)N)SC[C@@H]21 XFLVBMBRLSCJAI-ZKWXMUAHSA-N 0.000 description 1
- XFLVBMBRLSCJAI-UHFFFAOYSA-N biotin amide Natural products N1C(=O)NC2C(CCCCC(=O)N)SCC21 XFLVBMBRLSCJAI-UHFFFAOYSA-N 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000035425 carbon utilization Effects 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940125807 compound 37 Drugs 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- PFURGBBHAOXLIO-UHFFFAOYSA-N cyclohexane-1,2-diol Chemical compound OC1CCCCC1O PFURGBBHAOXLIO-UHFFFAOYSA-N 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 150000002019 disulfides Chemical group 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 238000002101 electrospray ionisation tandem mass spectrometry Methods 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 230000009483 enzymatic pathway Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- USURWZVIRCMXBG-UHFFFAOYSA-N ethyl 3-[2-[2-(3-ethoxy-3-oxopropoxy)ethoxy]ethoxy]propanoate Chemical compound CCOC(=O)CCOCCOCCOCCC(=O)OCC USURWZVIRCMXBG-UHFFFAOYSA-N 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 201000006440 gangliosidosis Diseases 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010054451 glucosamine acetyltransferase Proteins 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940022353 herceptin Drugs 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- ZUFVXZVXEJHHBN-UHFFFAOYSA-N hydron;1,2,3,4-tetrahydroacridin-9-amine;chloride Chemical compound [Cl-].C1=CC=C2C([NH3+])=C(CCCC3)C3=NC2=C1 ZUFVXZVXEJHHBN-UHFFFAOYSA-N 0.000 description 1
- HQZMRJBVCVYVQA-UHFFFAOYSA-N hydron;methyl 2-(methylamino)acetate;chloride Chemical compound Cl.CNCC(=O)OC HQZMRJBVCVYVQA-UHFFFAOYSA-N 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001871 ion mobility spectroscopy Methods 0.000 description 1
- 238000002218 isotachophoresis Methods 0.000 description 1
- 238000001948 isotopic labelling Methods 0.000 description 1
- GSXOAOHZAIYLCY-HSUXUTPPSA-N keto-D-fructose 6-phosphate Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O GSXOAOHZAIYLCY-HSUXUTPPSA-N 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 108700041430 link Proteins 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 229940040511 liver extract Drugs 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002534 molecular mass spectrometry Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 125000005496 phosphonium group Chemical group 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000768 polyamine Chemical group 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920006295 polythiol Chemical group 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004094 preconcentration Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000005267 prostate cell Anatomy 0.000 description 1
- 210000000064 prostate epithelial cell Anatomy 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 229940124272 protein stabilizer Drugs 0.000 description 1
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 1
- 238000010833 quantitative mass spectrometry Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000010845 search algorithm Methods 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000002098 selective ion monitoring Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- JLVSPVFPBBFMBE-HXSWCURESA-N sphingosine-1-phosphocholine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP([O-])(=O)OCC[N+](C)(C)C JLVSPVFPBBFMBE-HXSWCURESA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 108060007951 sulfatase Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium group Chemical group [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide-pyridine complex Substances O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000010846 tandem mass spectrometry analysis Methods 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical group CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/18—Sulfur containing
- Y10T436/182—Organic or sulfhydryl containing [e.g., mercaptan, hydrogen, sulfide, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9778898P | 1998-08-25 | 1998-08-25 | |
| US9911398P | 1998-09-03 | 1998-09-03 | |
| US60/097,788 | 1998-09-03 | ||
| US60/099,113 | 1998-09-03 | ||
| PCT/US1999/019415 WO2000011208A1 (en) | 1998-08-25 | 1999-08-25 | Rapid quantitative analysis of proteins or protein function in complex mixtures |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002208687A Division JP3793124B2 (ja) | 1998-08-25 | 2002-07-17 | 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002523058A JP2002523058A (ja) | 2002-07-30 |
| JP3345401B2 true JP3345401B2 (ja) | 2002-11-18 |
Family
ID=26793647
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000566460A Expired - Lifetime JP3345401B2 (ja) | 1998-08-25 | 1999-08-25 | 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析 |
| JP2002208687A Expired - Lifetime JP3793124B2 (ja) | 1998-08-25 | 2002-07-17 | 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析 |
| JP2006043216A Expired - Lifetime JP4117320B2 (ja) | 1998-08-25 | 2006-02-20 | 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002208687A Expired - Lifetime JP3793124B2 (ja) | 1998-08-25 | 2002-07-17 | 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析 |
| JP2006043216A Expired - Lifetime JP4117320B2 (ja) | 1998-08-25 | 2006-02-20 | 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6670194B1 (enExample) |
| EP (2) | EP1105517B2 (enExample) |
| JP (3) | JP3345401B2 (enExample) |
| AT (2) | ATE536422T1 (enExample) |
| AU (1) | AU755334C (enExample) |
| DE (1) | DE69912444T3 (enExample) |
| WO (1) | WO2000011208A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7180056B2 (en) | 2004-06-04 | 2007-02-20 | Hitachi, Ltd. | Mass spectrometry and mass spectrometry system |
Families Citing this family (264)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6379971B1 (en) | 1998-02-24 | 2002-04-30 | Target Discovery, Inc. | Methods for sequencing proteins |
| AU755334C (en) * | 1998-08-25 | 2004-02-26 | University Of Washington | Rapid quantitative analysis of proteins or protein function in complex mixtures |
| CA2361384A1 (en) * | 1999-02-11 | 2000-08-17 | Sun Ai Raillard | High throughput mass spectrometry |
| US6629040B1 (en) | 1999-03-19 | 2003-09-30 | University Of Washington | Isotope distribution encoded tags for protein identification |
| CA2369868A1 (en) * | 1999-04-15 | 2000-10-26 | The University Of Virginia Patent Foundation | Proteome mining |
| US6716636B1 (en) | 1999-04-20 | 2004-04-06 | Target Discovery, Inc. | Methods for sequencing proteins |
| US6764817B1 (en) | 1999-04-20 | 2004-07-20 | Target Discovery, Inc. | Methods for conducting metabolic analyses |
| US6937330B2 (en) | 1999-04-23 | 2005-08-30 | Ppd Biomarker Discovery Sciences, Llc | Disposable optical cuvette cartridge with low fluorescence material |
| EP1179175A2 (en) * | 1999-05-14 | 2002-02-13 | Karolinska Innovations AB | Materials and methods relating to disease diagnosis |
| US6960439B2 (en) | 1999-06-28 | 2005-11-01 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| US6692916B2 (en) | 1999-06-28 | 2004-02-17 | Source Precision Medicine, Inc. | Systems and methods for characterizing a biological condition or agent using precision gene expression profiles |
| US6687395B1 (en) * | 1999-07-21 | 2004-02-03 | Surromed, Inc. | System for microvolume laser scanning cytometry |
| US6783929B1 (en) | 1999-11-02 | 2004-08-31 | Chiron Corporation | Biological sample component purification and differential display |
| ATE340025T1 (de) * | 2000-01-06 | 2006-10-15 | Caliper Life Sciences Inc | Vorrichtungen und verfahren für hochdurchsatz- probenentnahme und analyse |
| AU2001227280A1 (en) | 2000-04-10 | 2001-10-23 | The Scripps Research Institute | Proteomic analysis using activity-based probe libraries |
| DE10021737C2 (de) * | 2000-05-04 | 2002-10-17 | Hermann Haller | Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird |
| ATE344456T1 (de) * | 2000-05-05 | 2006-11-15 | Purdue Research Foundation | Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen |
| US7153682B2 (en) | 2000-06-05 | 2006-12-26 | Chiron Corporation | Microarrays on mirrored substrates for performing proteomic analyses |
| US7148058B2 (en) | 2000-06-05 | 2006-12-12 | Chiron Corporation | Protein microarrays on mirrored surfaces for performing proteomic analyses |
| DE10027794A1 (de) * | 2000-06-07 | 2001-12-13 | Basf Ag | Verfahren zur Analyse Enzym-katalysierter Umsetzungen mit MALDI-TOF-Massenspektrometrie |
| AU2001269058A1 (en) * | 2000-06-07 | 2001-12-17 | Basf Aktiengesellschaft | Method for the qualitative and quantitative analysis of complex mixtures of chemical compounds, using maldi-tof mass spectrometry |
| CA2411126A1 (en) | 2000-06-09 | 2001-12-13 | Mds Proteomics, Inc. | Labeling of proteomic samples during proteolysis for quantitation and sample multiplexing |
| AU2001266894B2 (en) | 2000-06-12 | 2006-03-16 | University Of Washington | Selective labeling and isolation of phosphopeptides and applications to proteomeanalysis |
| US7567870B1 (en) | 2000-07-31 | 2009-07-28 | Institute For Systems Biology | Multiparameter analysis for predictive medicine |
| EP1350106A2 (en) * | 2000-08-11 | 2003-10-08 | Agilix Corporation | Ultra-sensitive detection systems |
| EP1332513A2 (en) * | 2000-08-25 | 2003-08-06 | Genencor International, Inc. | Detecting polymers and polymer fragments |
| DE10043470B4 (de) * | 2000-09-04 | 2006-01-19 | Mpb Meltec Patent- Und Beteiligungsgesellschaft Mbh | Verfahren zur Identifizierung von zellspezifischen Proteinen |
| WO2002029032A2 (en) * | 2000-09-30 | 2002-04-11 | Diversa Corporation | Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| SE0003566D0 (sv) * | 2000-10-02 | 2000-10-02 | Amersham Pharm Biotech Ab | A method for the quantitative determination of one or more compounds |
| EP1325322A2 (en) * | 2000-10-03 | 2003-07-09 | Dionex Corporation | Method and system for peak parking in liquid chromatography-mass spectrometer (lc-ms) analysis |
| US20040209251A1 (en) | 2000-10-19 | 2004-10-21 | Schneider Luke V | Methods for determining protein and peptide terminal sequences |
| EP1330654B1 (en) | 2000-10-23 | 2006-03-08 | Genetics Institute, LLC | Acid-labile isotope-coded extractant (alice) in mass spectometric analysis |
| AU4173202A (en) | 2000-10-23 | 2002-06-18 | Inst Genetics Llc | Isotope-coded ionization-enhancing reagents (icier) for high-throughput protein identification and quantitation using matrix-assisted laser desorption ionization mass spectrometry |
| WO2002042427A2 (en) * | 2000-10-25 | 2002-05-30 | Surromed, Inc. | Mass tags for quantitative analysis |
| SE0004094D0 (sv) * | 2000-11-09 | 2000-11-09 | Amersham Pharm Biotech Ab | A method for the quantification of carbohudrates |
| US6787761B2 (en) * | 2000-11-27 | 2004-09-07 | Surromed, Inc. | Median filter for liquid chromatography-mass spectrometry data |
| US20020095260A1 (en) * | 2000-11-28 | 2002-07-18 | Surromed, Inc. | Methods for efficiently mining broad data sets for biological markers |
| US6797523B2 (en) * | 2000-11-30 | 2004-09-28 | Affinium Pharmaceuticals, Inc. | Methods for systematic identification of protein—protein interactions |
| US20020090652A1 (en) * | 2000-12-22 | 2002-07-11 | Fu Emil Wei-Ming | Inverse labeling method for the rapid identification of marker/target proteins |
| US20020115056A1 (en) | 2000-12-26 | 2002-08-22 | Goodlett David R. | Rapid and quantitative proteome analysis and related methods |
| WO2002055989A2 (en) * | 2001-01-12 | 2002-07-18 | The Regents Of The University Of California | Stable isotope, site-specific mass tagging for protein identification |
| US7166436B2 (en) | 2001-01-26 | 2007-01-23 | Syngenta Participations, Ag | Differential labeling for quantitative analysis of complex protein mixtures |
| US6969757B2 (en) | 2001-01-26 | 2005-11-29 | Syngenta Participations Ag | Differential labeling for quantitative analysis of complex protein mixtures |
| WO2002063271A2 (en) * | 2001-02-05 | 2002-08-15 | Activx Biosciences, Inc. | Activity based probe analysis |
| US6818454B2 (en) | 2001-02-16 | 2004-11-16 | Battelle Memorial Institute | Phosphoprotein binding agents and methods of their use |
| DE60237194D1 (de) | 2001-03-02 | 2010-09-16 | Activx Biosciences Inc | Plattform für protein-profiling |
| WO2002077016A2 (en) * | 2001-03-22 | 2002-10-03 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore |
| EP1383920B1 (en) * | 2001-04-03 | 2010-09-29 | Thermo Finnigan Llc | Methods and kits useful for the simplification of complex peptide mixtures |
| CN1463291A (zh) * | 2001-04-19 | 2003-12-24 | 赛弗根生物系统股份有限公司 | 用质谱法和亲和标记物鉴定生物分子的特性 |
| US7045296B2 (en) * | 2001-05-08 | 2006-05-16 | Applera Corporation | Process for analyzing protein samples |
| US7183116B2 (en) | 2001-05-14 | 2007-02-27 | The Institute For Systems Biology | Methods for isolation and labeling of sample molecules |
| JP2005502030A (ja) * | 2001-05-29 | 2005-01-20 | リージェンツ オブ ザ ユニバーシティ オブ ミシガン | タンパク質解析のシステムおよび方法 |
| CA2349265A1 (en) * | 2001-05-30 | 2002-11-30 | Andrew Emili | Protein expression profile database |
| CA2453725A1 (en) * | 2001-07-13 | 2003-01-23 | Syngenta Participations Ag | System and method of determining proteomic differences |
| US6800449B1 (en) | 2001-07-13 | 2004-10-05 | Syngenta Participations Ag | High throughput functional proteomics |
| AU2002322506A1 (en) * | 2001-07-16 | 2003-03-03 | President And Fellows Of Harvard College | Non-affinity based isotope tagged peptides and methods for using the same |
| EP2053406A3 (en) | 2001-07-16 | 2009-06-24 | caprotec bioanalytics GmbH | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| US7343247B2 (en) | 2001-07-30 | 2008-03-11 | The Institute For Systems Biology | Methods of classifying drug responsiveness using multiparameter analysis |
| WO2003016861A2 (en) * | 2001-08-14 | 2003-02-27 | President And Fellows Of Harvard College | Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
| US6873915B2 (en) * | 2001-08-24 | 2005-03-29 | Surromed, Inc. | Peak selection in multidimensional data |
| AU2002341862C1 (en) * | 2001-09-27 | 2009-01-29 | Purdue Research Foundation | Controlling isotope effects during fractionation of analytes |
| US20030078739A1 (en) * | 2001-10-05 | 2003-04-24 | Surromed, Inc. | Feature list extraction from data sets such as spectra |
| US6756586B2 (en) | 2001-10-15 | 2004-06-29 | Vanderbilt University | Methods and apparatus for analyzing biological samples by mass spectrometry |
| DE10153631B4 (de) * | 2001-10-31 | 2006-04-13 | Lottspeich, Friedrich, Dr. | Verfahren zum Vergleich zweier Proteinzustände |
| US7132295B2 (en) | 2001-11-09 | 2006-11-07 | Bayer Aktiengesellschaft | Isotopically coded affinity markers 3 |
| KR20040064275A (ko) | 2001-11-09 | 2004-07-16 | 소스 프리시전 메디슨, 인코포레이티드 | 유전자 발현 프로파일을 이용한 질병의 동정, 모니터링,치료 및 생물학적 상태의 확인 |
| CA2466356A1 (en) * | 2001-11-09 | 2003-05-15 | Bayer Healthcare Ag | Isotopically coded affinity marker 2 |
| DE10154744A1 (de) * | 2001-11-09 | 2003-05-22 | Bayer Ag | Isotopencodierte Affinitätsmarker |
| WO2003042774A2 (en) * | 2001-11-13 | 2003-05-22 | Caprion Pharmaceuticals Inc. | Mass intensity profiling system and uses thereof |
| US20030091976A1 (en) * | 2001-11-14 | 2003-05-15 | Ciphergen Biosystems, Inc. | Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| DE10158860B4 (de) | 2001-11-30 | 2007-04-05 | Bruker Daltonik Gmbh | Massenspektrometrische Proteingemischanalyse |
| EP1319954A1 (en) * | 2001-12-12 | 2003-06-18 | Centre National de Genotypage | Methods for protein analysis using protein capture arrays |
| US7623969B2 (en) | 2002-01-31 | 2009-11-24 | The Institute For Systems Biology | Gene discovery for the system assignment of gene function |
| EP1483399B1 (en) * | 2002-02-12 | 2008-10-29 | The Regents of the University of California | Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| CA2475011C (en) * | 2002-02-14 | 2015-07-07 | Ajinomoto Co., Inc. | Method for analysis of compounds with amino group and analytical reagent therefor |
| DK1502102T3 (da) * | 2002-03-11 | 2009-05-04 | Caprotec Bioanalytics Gmbh | Forbindelser og fremgangsmåder til analysering af proteomet |
| US7288382B2 (en) | 2002-03-14 | 2007-10-30 | The Board Of Trustees Od The Leland Stanford Junior University | Methods for structural analysis of proteins |
| KR20040094856A (ko) * | 2002-03-25 | 2004-11-10 | 데이진 가부시키가이샤 | 생체 시료내 보효소 ａ 류의 측정방법 |
| WO2003087834A2 (en) * | 2002-04-08 | 2003-10-23 | Affinium Pharmaceuticals, Inc. | High throughput analysis of recombinant proteins in multi-well plates |
| US6989100B2 (en) * | 2002-05-09 | 2006-01-24 | Ppd Biomarker Discovery Sciences, Llc | Methods for time-alignment of liquid chromatography-mass spectrometry data |
| AU2003261074A1 (en) * | 2002-05-20 | 2003-12-02 | Jason M. Hogan | Protein identification from protein product ion spectra |
| US20040229294A1 (en) | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | ErbB surface receptor complexes as biomarkers |
| US7052916B2 (en) * | 2002-05-24 | 2006-05-30 | Immunex Corporation | Polypeptide analyses using stable isotope labeling |
| GB0212522D0 (en) * | 2002-05-31 | 2002-07-10 | Shimadzu Res Lab Europe Ltd | Selective binding and analysis of macromolecules |
| EP1514107B1 (en) | 2002-06-03 | 2013-05-15 | The Institute for Systems Biology | Methods for quantitative proteome analysis of glycoproteins |
| AU2003259029A1 (en) | 2002-06-04 | 2003-12-19 | The Institute For Systems Biology | Methods for high throughput and quantitative proteome analysis |
| JP2005529335A (ja) * | 2002-06-10 | 2005-09-29 | フィネクサス， インク． | 開放チャンネルを使って生体分子を固体相として抽出するシステムと方法 |
| DE10227599B4 (de) * | 2002-06-20 | 2005-04-28 | Proteome Factory Ag | Verfahren und Reagenz zur spezifischen Identifizierung und Quantifizierung von einem oder mehreren Proteinen in einer Probe |
| AU2003236369A1 (en) * | 2002-06-28 | 2004-01-19 | Shimadzu Corporation | Sulfenyl compound, labeling reagent, and method of analyzing peptide |
| AU2003252593A1 (en) | 2002-07-10 | 2004-02-02 | Seikagaku Corporation | Sulfotransferase inhibitors |
| CA2393726A1 (en) * | 2002-07-16 | 2004-01-16 | Steven J. Locke | Quantitative proteomics via isotopically differentiated derivatization |
| GB0305796D0 (en) | 2002-07-24 | 2003-04-16 | Micromass Ltd | Method of mass spectrometry and a mass spectrometer |
| US7409296B2 (en) * | 2002-07-29 | 2008-08-05 | Geneva Bioinformatics (Genebio), S.A. | System and method for scoring peptide matches |
| AU2003256819B2 (en) * | 2002-07-30 | 2009-11-12 | The Regents Of The University Of California | Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| US7501286B2 (en) | 2002-08-14 | 2009-03-10 | President And Fellows Of Harvard College | Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
| US7473535B2 (en) | 2002-08-20 | 2009-01-06 | The Institute For Systems Biology | Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
| JP4395439B2 (ja) * | 2002-09-12 | 2010-01-06 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） | 薬物標的の同定のための方法 |
| EP1546359A4 (en) | 2002-09-12 | 2007-05-09 | Molecular Probes Inc | JOB-SPECIFIC MARKING OF AFFINITY DAYS IN FUSION PROTEINS |
| WO2004036189A2 (en) | 2002-10-18 | 2004-04-29 | Promega Corporation | Methods for separating molecules |
| US6944549B2 (en) * | 2002-10-25 | 2005-09-13 | Syngenta Participations Ag | Method and apparatus for automated detection of peaks in spectroscopic data |
| EP2595173B1 (en) | 2002-10-29 | 2016-09-14 | Target Discovery, Inc. | Method for increasing ionization efficiency in mass spectroscopy |
| US7846748B2 (en) | 2002-12-02 | 2010-12-07 | The University Of North Carolina At Chapel Hill | Methods of quantitation and identification of peptides and proteins |
| US7425451B2 (en) | 2002-12-13 | 2008-09-16 | Agilent Technologies, Inc. | Triazine derivatives as universal peptide isotope tag reagents (U-PIT) |
| US7109040B2 (en) * | 2002-12-13 | 2006-09-19 | Agilent Technologies, Inc. | Modular isotope coding approach to proteomic analysis |
| US20060105343A1 (en) * | 2003-01-09 | 2006-05-18 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of cancer |
| US7422865B2 (en) * | 2003-01-13 | 2008-09-09 | Agilent Technologies, Inc. | Method of identifying peptides in a proteomic sample |
| EP1583972B1 (en) * | 2003-01-16 | 2010-11-24 | caprotec bioanalytics GmbH | Methods for identifying drug non-target proteins |
| US20040219685A1 (en) | 2003-01-30 | 2004-11-04 | Applera Corporation | Methods and mixtures pertaining to analyte determination using electrophilic labeling reagents |
| WO2004079370A1 (en) * | 2003-03-03 | 2004-09-16 | Universiteit Leiden | Analysis of the proteome of a living cell by labelling the proteins in the intact cell |
| TW200508606A (en) * | 2003-03-07 | 2005-03-01 | Nard Kenkyusho Kk | Method of finding molecular weight of phosphoric acid monoester compound, and additive for mass spectrometric measurement |
| CA2521130C (en) | 2003-04-01 | 2013-05-14 | Activx Biosciences, Inc. | Acyl-phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| WO2004097372A2 (en) | 2003-04-28 | 2004-11-11 | The Regents Of The University Of California | Element-coded affinity tags |
| US7267994B2 (en) | 2003-04-28 | 2007-09-11 | Regents Of The University Of California | Element-coded affinity tags |
| GB0311961D0 (en) | 2003-05-23 | 2003-06-25 | Health Prot Agency | Mass-based toxin assay and substrates therefor |
| EP1631553A4 (en) * | 2003-06-06 | 2008-09-10 | Harvard College | PEPTIDES BASED ON CAPTURE AND RELEASE BASED ISOTOPES AND METHODS OF USING PEPTIDES |
| CA2529863A1 (en) * | 2003-06-17 | 2004-12-23 | Vib Vzw | Peptide combos and their uses |
| GB0314209D0 (en) * | 2003-06-19 | 2003-07-23 | Amersham Biosciences Ab | Novel MS reagents |
| WO2005007677A2 (en) | 2003-07-10 | 2005-01-27 | The Institute For Systems Biology | Affinity capture of peptides by microarray and related methods |
| FR2857451B1 (fr) * | 2003-07-11 | 2005-09-30 | Commissariat Energie Atomique | Procede et dispositif pour l'analyse de milieux reactionnels vivants |
| CA2535510C (en) * | 2003-08-11 | 2013-10-15 | Monogram Biosciences, Inc. | Detecting and profiling molecular complexes |
| US20050048499A1 (en) * | 2003-08-29 | 2005-03-03 | Perkin Elmer Life Sciences, Inc. | Tandem mass spectrometry method for the genetic screening of inborn errors of metabolism in newborns |
| WO2005022156A1 (ja) * | 2003-08-29 | 2005-03-10 | Reverse Proteomics Research Institute Co., Ltd. | タンパク質の固定化方法 |
| US7485435B2 (en) * | 2004-08-30 | 2009-02-03 | Perkinelmer Las, Inc. | Simultaneous detection of metabolic enzyme activity and metabolite levels |
| US20050074895A1 (en) * | 2003-09-05 | 2005-04-07 | Bio-Rad Laboratories, Inc. | Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins |
| US7081623B2 (en) | 2003-09-05 | 2006-07-25 | Lucent Technologies Inc. | Wafer-based ion traps |
| WO2005031304A2 (en) * | 2003-09-22 | 2005-04-07 | Becton, Dickinson And Company | Quantification of analytes using internal standards |
| US7145019B2 (en) * | 2003-10-16 | 2006-12-05 | Ambergen, Inc. | Photocleavable isotope-coded affinity tags |
| US7348416B2 (en) * | 2003-11-21 | 2008-03-25 | Applera Corporation | Selective capture and enrichment of proteins expressed on the cell surface |
| EP1686372A4 (en) * | 2003-11-21 | 2009-04-01 | Eisai R&D Man Co Ltd | QUANTIFICATION METHOD USING AN ISOTOPE-MARKED INTERNAL CALIBRATION, ANALYSIS SYSTEM FOR EXECUTING THE QUANTIFICATION METHOD AND ASSOCIATED SEPARATION PROGRAM |
| US20050202406A1 (en) * | 2003-11-25 | 2005-09-15 | The Regents Of The University Of California | Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| US20050148771A1 (en) | 2004-01-05 | 2005-07-07 | Applera Corporation. | Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof |
| US7355045B2 (en) | 2004-01-05 | 2008-04-08 | Applera Corporation | Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof |
| WO2005069891A2 (en) * | 2004-01-15 | 2005-08-04 | Cedars-Sinai Medical Center | System and method for expression proteomics based on isotope ratio modification |
| US20070087448A1 (en) * | 2004-02-16 | 2007-04-19 | Nelsestuen Gary L | Biological profiles and methods of use |
| TW200538738A (en) | 2004-02-20 | 2005-12-01 | Univ California | Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
| EP1731908B1 (en) * | 2004-03-31 | 2010-09-01 | Kazuo Shinya | Method of biosubstance trapping, structural analysis or/and identification with use of a labeling substance |
| US7248360B2 (en) * | 2004-04-02 | 2007-07-24 | Ppd Biomarker Discovery Sciences, Llc | Polychronic laser scanning system and method of use |
| JP4861308B2 (ja) * | 2004-04-07 | 2012-01-25 | ジェネンテック， インコーポレイテッド | 抗体結合体の質量分析 |
| US20080206737A1 (en) * | 2004-05-19 | 2008-08-28 | Hunter Christie L | Expression quantification using mass spectrometry |
| US20070054345A1 (en) * | 2004-05-19 | 2007-03-08 | Hunter Christie L | Expression quantification using mass spectrometry |
| EP1766413A2 (en) * | 2004-05-19 | 2007-03-28 | Applera Corporation | Expression quantification using mass spectrometry |
| DK1766412T3 (da) | 2004-05-21 | 2009-05-25 | Inst Systems Biology | Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner |
| US20080044857A1 (en) * | 2004-05-25 | 2008-02-21 | The Gov Of Usa As Represented By The Secretary Of | Methods For Making And Using Mass Tag Standards For Quantitative Proteomics |
| WO2005116629A1 (ja) * | 2004-05-26 | 2005-12-08 | Ajinomoto Co., Inc. | アミノ官能性化合物の分析方法及び装置 |
| WO2006091214A2 (en) * | 2004-06-18 | 2006-08-31 | Molecular Probes, Inc. | Fluorescent isotope tags and their method of use |
| CA2572754A1 (en) * | 2004-07-12 | 2006-02-16 | Applera Corporation | Mass tags for quantitative analyses |
| US20070048752A1 (en) | 2004-07-12 | 2007-03-01 | Applera Corporation | Mass tags for quantitative analyses |
| US20060024757A1 (en) | 2004-07-30 | 2006-02-02 | Robert Hussa | Detection of oncofetal fibronectin for selection of concepti |
| US7592139B2 (en) * | 2004-09-24 | 2009-09-22 | Sandia National Laboratories | High temperature flow-through device for rapid solubilization and analysis |
| JP4563764B2 (ja) * | 2004-10-01 | 2010-10-13 | 丸善製薬株式会社 | ペプチドの定量方法 |
| EP1814908A4 (en) * | 2004-11-22 | 2009-07-01 | Biosight Ltd | Activated labeling reagents and method for their preparation and use |
| US20060183238A1 (en) | 2005-02-09 | 2006-08-17 | Applera Corporation | Amine-containing compound analysis methods |
| US20070037286A1 (en) * | 2005-02-09 | 2007-02-15 | Subhasish Purkayastha | Thyroxine-containing compound analysis methods |
| WO2006096704A2 (en) | 2005-03-07 | 2006-09-14 | Invitrogen Corporation | Isotopically-labeled proteome standards |
| US20060251576A1 (en) * | 2005-05-03 | 2006-11-09 | The Regents Of The University Of California | Methods for measuring cholesterol metabolism and transport |
| US10687785B2 (en) | 2005-05-12 | 2020-06-23 | The Trustees Of Columbia Univeristy In The City Of New York | System and method for electromechanical activation of arrhythmias |
| DE602005004902T2 (de) * | 2005-06-02 | 2008-10-16 | Entelechon Gmbh | Künstliches Protein, Verfahren für absolute Quantifizierung der Proteine und seine Benutzung |
| JP2006337176A (ja) * | 2005-06-02 | 2006-12-14 | Eisai R & D Management Co Ltd | 代謝物の定量方法 |
| TW200711660A (en) * | 2005-06-10 | 2007-04-01 | Univ California | Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development |
| EP1754972A1 (en) | 2005-08-17 | 2007-02-21 | Agilent Technologies, Inc. | Folded peptides containing metal binding pockets for protein tagging |
| JP5199101B2 (ja) * | 2005-10-13 | 2013-05-15 | アプライド バイオシステムズ リミテッド ライアビリティー カンパニー | 生体分子の検定を開発するための方法 |
| US7998717B2 (en) | 2005-12-02 | 2011-08-16 | Pacific Biosciences Of California, Inc. | Mitigation of photodamage in analytical reactions |
| WO2007065273A1 (en) * | 2005-12-08 | 2007-06-14 | The University Of British Columbia | Mucopolysaccharidosis (mps) diagnostic methods, systems, kits and assays associated therewith |
| US20070140967A1 (en) * | 2005-12-19 | 2007-06-21 | Wood Nichole L | Agents and methods for analyzing protein interactions |
| US20070166810A1 (en) * | 2005-12-23 | 2007-07-19 | Perkinelmer Las, Inc. | Methods and compositions for detecting enzymatic activity |
| US20070148721A1 (en) * | 2005-12-28 | 2007-06-28 | Agilent Technologies, Inc. | Compositions, methods, systems, and kits for affinity purification |
| WO2007078229A1 (en) * | 2006-01-05 | 2007-07-12 | Ge Healthcare Bio-Sciences Ab | Kit and method for mass labelling |
| WO2008048345A2 (en) * | 2006-02-14 | 2008-04-24 | Perkinelmer Las, Inc. | Detection systems for mass labels |
| WO2008076139A1 (en) | 2006-03-10 | 2008-06-26 | Tethys Bioscience, Inc. | Multiplex protein fractionation |
| EP1999270A4 (en) * | 2006-03-13 | 2010-04-28 | Perkinelmer Las Inc | SUBSTRATES AND INTERNAL STANDARDS FOR MASS SPECTROSCOPY DETECTION |
| US20090215098A1 (en) * | 2006-04-28 | 2009-08-27 | Ucl Business Plc. | Quantification of enzyme activity by mass spectrometry |
| US20100216657A1 (en) * | 2006-05-16 | 2010-08-26 | Arcxis Biotechnologies, Inc. | Pcr-free sample preparation and detection systems for high speed biologic analysis and identification |
| WO2008094205A2 (en) * | 2006-08-04 | 2008-08-07 | The Board Of Trustees Of The Leland Stanford Junior University | A mild chemically cleavable linker system |
| US7879799B2 (en) * | 2006-08-10 | 2011-02-01 | Institute For Systems Biology | Methods for characterizing glycoproteins and generating antibodies for same |
| EP1916526A1 (en) * | 2006-10-26 | 2008-04-30 | Koninklijke Philips Electronics N.V. | Method for diagnostic and therapeutic target discovery by combining isotopic and isobaric labels |
| EP1921081A1 (en) * | 2006-11-06 | 2008-05-14 | Koninklijke Philips Electronics N.V. | Use of arylboronic acids in protein labelling |
| SI2436696T1 (sl) | 2007-01-05 | 2017-10-30 | University Of Zurich | Anti-beta-amiloidno protitelo in načini njegove uporabe |
| KR100805777B1 (ko) * | 2007-02-22 | 2008-02-21 | 한국기초과학지원연구원 | 질량 스펙트럼 데이터 및 １차원 젤에서의 밴드 위치분석을 포함하는 단백질 수식화 분석 시스템 및 이를이용한 단백질 수식화 분석 방법 |
| CA2690612C (en) | 2007-05-14 | 2016-07-05 | Historx, Inc. | Compartment segregation by pixel characterization using image data clustering |
| JP5003274B2 (ja) * | 2007-05-16 | 2012-08-15 | 株式会社日立製作所 | 質量分析システムおよび質量分析方法 |
| WO2008150488A1 (en) * | 2007-06-01 | 2008-12-11 | Laboratory Corporation Of America Holdings | Methods and systems for quantification of peptides and other analytes |
| JP5593221B2 (ja) | 2007-06-15 | 2014-09-17 | ヒストロックス，インコーポレイテッド． | 顕微鏡機器を標準化するための方法およびシステム |
| JP4883540B2 (ja) * | 2007-06-21 | 2012-02-22 | 国立大学法人福井大学 | 同位体化合物を標識として使用するタンパク質の分析方法 |
| EP2015076A1 (en) * | 2007-07-11 | 2009-01-14 | Koninklijke Philips Electronics N.V. | Protein labelling with tags comprising isotope-coded sub-tags and isobaric sub-tags |
| CA2604317C (en) | 2007-08-06 | 2017-02-28 | Historx, Inc. | Methods and system for validating sample images for quantitative immunoassays |
| CA2596204C (en) | 2007-08-07 | 2019-02-26 | Historx, Inc. | Method and system for determining an optimal dilution of a reagent |
| WO2009026252A1 (en) * | 2007-08-17 | 2009-02-26 | University Of Washington | Methods for assaying alpha-l-iduronidase enzymatic activity |
| US7978258B2 (en) | 2007-08-31 | 2011-07-12 | Historx, Inc. | Automatic exposure time selection for imaging tissue |
| JP4921302B2 (ja) * | 2007-09-26 | 2012-04-25 | 株式会社日立ハイテクノロジーズ | 質量分析システム |
| US8604692B2 (en) | 2007-11-06 | 2013-12-10 | Translational Therapeutics, Inc. | Mass spectrometry assay for eIF4E and eIF4E regulon activity |
| WO2009061904A2 (en) * | 2007-11-06 | 2009-05-14 | Translational Therapeutics, Inc. | MASS SPECTROMETRY ASSAY FOR eIF4E AND eIF4E REGULON ACTIVITY |
| US8334506B2 (en) | 2007-12-10 | 2012-12-18 | 1St Detect Corporation | End cap voltage control of ion traps |
| BRPI0906090A2 (pt) * | 2008-03-13 | 2016-05-03 | Perkinelmar Las Inc | substrato para análise de uma enzima, molécula e método para detectar atividade enzimática . |
| EP2108957A1 (en) * | 2008-04-07 | 2009-10-14 | Koninklijke Philips Electronics N.V. | Compounds and methods for the labelling and affinity-selection of proteins |
| US7973277B2 (en) | 2008-05-27 | 2011-07-05 | 1St Detect Corporation | Driving a mass spectrometer ion trap or mass filter |
| CA2725599A1 (en) | 2008-05-30 | 2009-12-03 | The University Of British Columbia | Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling |
| US20110151494A1 (en) | 2008-06-30 | 2011-06-23 | H. Lee Moffit Cancer & Research Institute | Methods and materials for monitoring myeloma using quantitative mass spectrometry |
| US9240043B2 (en) | 2008-09-16 | 2016-01-19 | Novartis Ag | Reproducible quantification of biomarker expression |
| US20100081924A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
| US20100081915A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, Alimited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
| US20100081927A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
| US20100081928A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological Facilitation systems and methods |
| US20100081916A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware. | Histological facilitation systems and methods |
| US20100081926A1 (en) * | 2008-09-29 | 2010-04-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Histological facilitation systems and methods |
| US8673267B2 (en) | 2009-03-02 | 2014-03-18 | Massachusetts Institute Of Technology | Methods and products for in vivo enzyme profiling |
| US8227251B2 (en) * | 2009-04-14 | 2012-07-24 | Institute For Systems Biology | Mass spectrum-based identification and quantitation of proteins and peptides |
| WO2010133173A1 (en) * | 2009-05-21 | 2010-11-25 | Rongxiu Li | Process for differential polypeptides detection and uses thereof |
| GB0916881D0 (en) | 2009-09-25 | 2009-11-11 | Electrophoretics Ltd | Mass labels |
| EP2309262A1 (en) | 2009-10-06 | 2011-04-13 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for quantifying biomolecules |
| WO2011075530A1 (en) * | 2009-12-15 | 2011-06-23 | Dh Technologies Development Pte. Ltd. | Analysis of amino acids and amine-containing compounds using tagging reagents and lc-ms workflow |
| AU2010340358B2 (en) | 2009-12-21 | 2014-07-24 | Pharmathene, Inc. | Recombinant butyrylcholinesterases and truncates thereof |
| WO2011087869A1 (en) * | 2009-12-22 | 2011-07-21 | Expression Pathology, Inc. | Secreted protein acidic and rich in cysteine (sparc) protein srm/mrm assay |
| DK2517011T3 (en) * | 2009-12-22 | 2015-11-23 | Expression Pathology Inc | SRM / MRM analysis for the receptor protein for the insulin-like growth factor 1 (IGF-1R) |
| US9453845B2 (en) | 2010-02-01 | 2016-09-27 | Cell Signaling Technology, Inc. | Mass spectroscopy analysis of mutant polypeptides in biological samples |
| DE102011017084B4 (de) | 2010-04-14 | 2020-07-09 | Wisconsin Alumni Research Foundation | Massenspektrometriedaten-Erfassungsmodus zur Erzielung einer zuverlässigeren Proteinquantifizierung |
| WO2012003478A2 (en) | 2010-07-02 | 2012-01-05 | Ventana Medical Systems, Inc. | Detecting targets using mass tags and mass spectrometry |
| WO2012021733A2 (en) | 2010-08-12 | 2012-02-16 | Pacific Biosciences Of California, Inc. | Photodamage mitigation compounds and systems |
| US8742333B2 (en) | 2010-09-17 | 2014-06-03 | Wisconsin Alumni Research Foundation | Method to perform beam-type collision-activated dissociation in the pre-existing ion injection pathway of a mass spectrometer |
| CN103547679A (zh) * | 2010-11-24 | 2014-01-29 | Dh科技发展私人贸易有限公司 | 葡萄糖-6-磷酸脱氢酶的高产量、灵敏检测 |
| US8492163B2 (en) | 2011-01-31 | 2013-07-23 | Dh Technologies Development Pte. Ltd. | Methods, mixtures, kits and compositions pertaining to analyte determination |
| ES2881535T3 (es) | 2011-03-15 | 2021-11-29 | Massachusetts Inst Technology | Detección multiplexada con indicadores codificados con isótopos |
| DE102012102875B4 (de) | 2011-04-04 | 2024-04-18 | Wisconsin Alumni Research Foundation | Vorläuferauswahl mit einem Artificial-Intelligence-Algorithmus erhöht Abdeckung und Reproduzierbarkeit von proteomischen Proben |
| US9659146B2 (en) | 2011-05-02 | 2017-05-23 | Tyler Stuart Bray | Method for quantitative analysis of complex proteomic data |
| WO2012162664A1 (en) | 2011-05-26 | 2012-11-29 | The Trustees Of Columbia University In The City Of New York | Systems and methods for opening of a tissue barrier in primates |
| WO2013036885A1 (en) | 2011-09-08 | 2013-03-14 | The Regents Of The University Of California | Metabolic flux measurement, imaging and microscopy |
| EP2802670B1 (en) | 2011-11-08 | 2019-12-25 | University of Washington | Lysosomal enzyme assay methods and compositions |
| EP2788772B1 (en) | 2011-12-07 | 2018-02-14 | GlaxoSmithKline LLC | Methods for determining total body skeletal muscle mass |
| DE102013212179A1 (de) * | 2012-07-31 | 2014-02-06 | Agilent Technologies, Inc. | Derivatisierung von PNGase F-freigesetzter Glykane auf einem HPLC-Chip |
| RU2015126651A (ru) | 2012-12-10 | 2017-01-16 | Фред Хатчинсон Кэнсер Рисёрч Сентер | Способы скрининга |
| EP4414372A3 (en) | 2013-03-15 | 2024-10-02 | Perkinelmer Health Sciences Inc. | Compounds and methods relating to testing for lysosomal storage disorders |
| US9134319B2 (en) | 2013-03-15 | 2015-09-15 | The Regents Of The University Of California | Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo |
| WO2014190234A1 (en) | 2013-05-23 | 2014-11-27 | Iphenotype Llc | Method and system for maintaining or improving wellness |
| JP6847660B2 (ja) | 2013-06-07 | 2021-03-24 | マサチューセッツ インスティテュート オブ テクノロジー | リガンドをコードする合成バイオマーカーのアフィニティベースの検出 |
| CN109813914A (zh) * | 2013-06-07 | 2019-05-28 | 皮尔斯生物科技有限公司 | 通过质谱分析用复用内标物对蛋白质和蛋白质修饰的绝对定量 |
| JP6482577B2 (ja) * | 2014-12-29 | 2019-03-13 | 株式会社日立ハイテクノロジーズ | 分析方法、及び分析装置 |
| EP3289107B1 (en) | 2015-05-01 | 2024-12-11 | The University of British Columbia | Biomarkers for the detection of acute rejection in heart transplantation |
| WO2017040976A1 (en) * | 2015-09-02 | 2017-03-09 | Erkki Ruoslahti | Compounds and compositions for targeting brain injuries and methods of use thereof |
| CN105384785B (zh) * | 2015-11-24 | 2018-06-19 | 中国人民解放军第二军医大学 | 含有半乳糖类脂肪酸衍生物的制备方法及其在医药领域的应用 |
| AU2016380362B2 (en) * | 2015-12-31 | 2021-07-01 | University Of Notre Dame Du Lac | ESI-MS via an electrokinetically pumped interface |
| EP3405783B1 (en) | 2016-01-22 | 2022-03-09 | Purdue Research Foundation | Charged mass labeling system |
| CN105911101B (zh) * | 2016-04-08 | 2018-09-11 | 中南大学 | 一种简单灵敏的膜性能检测方法 |
| WO2017177115A1 (en) | 2016-04-08 | 2017-10-12 | Massachusetts Institute Of Technology | Methods to specifically profile protease activity at lymph nodes |
| WO2017193070A1 (en) | 2016-05-05 | 2017-11-09 | Massachusetts Institute Of Technology | Methods and uses for remotely triggered protease activity measurements |
| JPWO2018003652A1 (ja) * | 2016-06-29 | 2019-05-16 | 株式会社日立ハイテクノロジーズ | 酵素反応及び質量分析方法に用いる化合物 |
| US11339434B2 (en) * | 2016-07-29 | 2022-05-24 | The Regents Of The University Of California | Methods for determining gene functions |
| DE102017103600A1 (de) * | 2017-02-22 | 2018-08-23 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Radioaktiv markiertes beta-Galactosidase Substrat für PET Bildgebung der Seneszenz |
| US11519905B2 (en) | 2017-04-07 | 2022-12-06 | Massachusetts Institute Of Technology | Methods to spatially profile protease activity in tissue and sections |
| WO2018213331A1 (en) * | 2017-05-16 | 2018-11-22 | Lankenau Institute For Medical Research | Compositions comprising ligands to rhob protein and the uses thereof |
| CN107325154B (zh) * | 2017-06-23 | 2020-11-20 | 广东华肽生物科技有限公司 | 一种具有改善记忆功效的多肽及其分离制备方法和用途 |
| CN108169397B (zh) * | 2017-11-30 | 2019-11-15 | 中国农业科学院北京畜牧兽医研究所 | 一种相对定量分析肉鸡谷胱甘肽s转移酶gsta2的方法 |
| EP3739328A4 (en) * | 2018-01-09 | 2021-10-20 | Shimadzu Corporation | PROCESS FOR IDENTIFYING PROTEINS |
| WO2019173332A1 (en) | 2018-03-05 | 2019-09-12 | Massachusetts Institute Of Technology | Inhalable nanosensors with volatile reporters and uses thereof |
| US10656059B2 (en) | 2018-03-07 | 2020-05-19 | Alcala Pharmaceutical, Inc. | Method for qualitative and quantitative multiplexing of drug analytes from biological samples |
| RU2678090C1 (ru) * | 2018-05-28 | 2019-01-23 | Федеральное государственное бюджетное научное учреждение "Федеральный научный центр пищевых систем им. В.М. Горбатова" РАН | Способ подтверждения аутентичности вареных колбасных изделий |
| US12173349B2 (en) | 2018-09-25 | 2024-12-24 | Massachusetts Institute Of Technology | Lung protease nanosensors and uses thereof |
| US11835522B2 (en) | 2019-01-17 | 2023-12-05 | Massachusetts Institute Of Technology | Sensors for detecting and imaging of cancer metastasis |
| WO2020154541A1 (en) * | 2019-01-24 | 2020-07-30 | The Board Of Trustees Of The Leland Stanford Junior University | Compact hydroxamate-based affinity tags for artificially tagging biological macromolecules |
| CN110280229B (zh) * | 2019-06-28 | 2022-03-11 | 东南大学 | 喋呤类化合物选择性分离富集材料制备与应用方法 |
| CN115769056A (zh) * | 2020-06-09 | 2023-03-07 | 里珍纳龙药品有限公司 | 用于定量抗体的高通量和基于质谱的方法 |
| EP4229074A1 (en) | 2020-10-16 | 2023-08-23 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Anti-tumor immunity induces the presentation of aberrant peptides |
| CN116829922A (zh) * | 2020-12-17 | 2023-09-29 | 豪夫迈·罗氏有限公司 | 用于质谱法的基于蒸发的样品制备工作流程 |
| CN113156002A (zh) * | 2021-04-01 | 2021-07-23 | 河北利德检测技术有限公司 | 一种葡萄糖酸钙中5种有关物质的检测方法 |
| WO2023080788A1 (en) | 2021-11-05 | 2023-05-11 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Tryptophan depletion induces production and presentation of tryptophan to phenylalanine substitutions |
| WO2024238393A1 (en) * | 2023-05-10 | 2024-11-21 | Northwestern University | Proteoform imaging and characterization mass spectrometry |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614368A (en) | 1990-02-09 | 1997-03-25 | Molecular Devices Corporation | Chromophoric reagents for incorporation of biotin or other haptens into macromolecules |
| US5650270A (en) | 1982-02-01 | 1997-07-22 | Northeastern University | Molecular analytical release tags and their use in chemical analysis |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4798795A (en) | 1987-02-17 | 1989-01-17 | Hoechst Celanese Corporation | Biotinylating agents |
| WO1990004786A1 (en) * | 1988-10-17 | 1990-05-03 | Molecular Devices Corporation | Hapten derivatized capture membrane and diagnostic assays using such membrane |
| US5438017A (en) * | 1989-05-01 | 1995-08-01 | The University Of Colorado Foundation, Inc. | Assays for sulfhydryl amino acids and methylmalonic acid and their application to diagnosis of cobalamin deficiency |
| CA1340966C (en) | 1989-05-19 | 2000-04-18 | Thomas R. Covey | Method of protein analysis |
| US5534440A (en) | 1991-02-22 | 1996-07-09 | Biomedical Research Centre Limited | Compounds and methods for sequencing amino acids |
| US5240859A (en) | 1991-02-22 | 1993-08-31 | B.R. Centre Limited | Methods for amino acid sequencing of a polypeptide |
| DE4310142A1 (de) | 1993-03-29 | 1994-10-06 | Boehringer Mannheim Gmbh | Immunologisch aktive Konjugate und ein Verfahren zu ihrer Herstellung |
| US5496934A (en) | 1993-04-14 | 1996-03-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Nucleic acids encoding a cellulose binding domain |
| US5491071A (en) * | 1993-08-03 | 1996-02-13 | Abbott Laboratories | Reagents and methods for the detection and quantification of testosterone in fluid samples |
| US5854084A (en) | 1996-07-12 | 1998-12-29 | Biotraces, Inc. | Enhanced chromatography using multiphoton detection |
| US5527711A (en) | 1993-12-13 | 1996-06-18 | Hewlett Packard Company | Method and reagents for binding chemical analytes to a substrate surface, and related analytical devices and diagnostic techniques |
| DE4343479A1 (de) * | 1993-12-21 | 1995-06-22 | Boehringer Mannheim Gmbh | Acylierte Proteinaggregate und deren Verwendung zur Entstörung von Immunoassays |
| JP3027770B2 (ja) * | 1994-03-05 | 2000-04-04 | ロシュ ダイアグノスティックス ゲーエムベーハー | イムノアッセイで使用するための干渉除去剤 |
| US6017693A (en) | 1994-03-14 | 2000-01-25 | University Of Washington | Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry |
| US5986076A (en) * | 1994-05-11 | 1999-11-16 | Trustees Of Boston University | Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| US5534132A (en) | 1995-05-04 | 1996-07-09 | Vreeke; Mark | Electrode and method for the detection of an affinity reaction |
| US5686310A (en) | 1995-06-06 | 1997-11-11 | University Of Virginia Patent Foundation | Method for determination of the amount of either phosphotyrosine or phosphoserine in a protein |
| US5965457A (en) | 1995-06-06 | 1999-10-12 | Magnani; John L. | Methods of screening for a candidate compound able to bind to CD34+ cells |
| WO1996040662A2 (en) | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
| CA2223261C (en) | 1995-06-07 | 2010-05-11 | Immunomedics, Inc. | Improved delivery of diagnostic and therapeutic agents to a target site |
| US5958703A (en) | 1996-12-03 | 1999-09-28 | Glaxo Group Limited | Use of modified tethers in screening compound libraries |
| JP2001524808A (ja) | 1996-12-10 | 2001-12-04 | ジーントレイス・システムズ・インコーポレイテッド | 放出可能な不揮発性の質量標識分子 |
| WO1998032876A1 (en) | 1997-01-23 | 1998-07-30 | Brax Group Limited | Characterising polypeptides |
| NZ502088A (en) | 1997-07-11 | 2002-05-31 | Brax Group Ltd | Characterising nucleic acids using mass spectroscopy |
| EP0994968A1 (en) | 1997-07-11 | 2000-04-26 | Brax Group Limited | Characterising nucleic acid |
| AU755334C (en) * | 1998-08-25 | 2004-02-26 | University Of Washington | Rapid quantitative analysis of proteins or protein function in complex mixtures |
| AU2001266894B2 (en) | 2000-06-12 | 2006-03-16 | University Of Washington | Selective labeling and isolation of phosphopeptides and applications to proteomeanalysis |
-
1999
- 1999-08-25 AU AU56913/99A patent/AU755334C/en not_active Expired
- 1999-08-25 DE DE69912444T patent/DE69912444T3/de not_active Expired - Lifetime
- 1999-08-25 EP EP99943915A patent/EP1105517B2/en not_active Expired - Lifetime
- 1999-08-25 AT AT03075828T patent/ATE536422T1/de active
- 1999-08-25 US US09/383,062 patent/US6670194B1/en not_active Expired - Lifetime
- 1999-08-25 WO PCT/US1999/019415 patent/WO2000011208A1/en not_active Ceased
- 1999-08-25 JP JP2000566460A patent/JP3345401B2/ja not_active Expired - Lifetime
- 1999-08-25 AT AT99943915T patent/ATE253126T1/de not_active IP Right Cessation
- 1999-08-25 EP EP03075828A patent/EP1329513B1/en not_active Expired - Lifetime
-
2001
- 2001-04-20 US US09/839,884 patent/US6852544B2/en not_active Expired - Lifetime
-
2002
- 2002-07-17 JP JP2002208687A patent/JP3793124B2/ja not_active Expired - Lifetime
-
2004
- 2004-11-23 US US10/994,815 patent/US7544518B2/en not_active Expired - Fee Related
-
2006
- 2006-02-20 JP JP2006043216A patent/JP4117320B2/ja not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5650270A (en) | 1982-02-01 | 1997-07-22 | Northeastern University | Molecular analytical release tags and their use in chemical analysis |
| US5614368A (en) | 1990-02-09 | 1997-03-25 | Molecular Devices Corporation | Chromophoric reagents for incorporation of biotin or other haptens into macromolecules |
Non-Patent Citations (1)
| Title |
|---|
| Ｎａｔｕｒｅ Ｂｉｏｔｅｃｈ．，Ｖｏｌ．１７，Ｎｏ．１０，Ｐ．９９４−９９９（Ｏｃｔ．１９９９） |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7180056B2 (en) | 2004-06-04 | 2007-02-20 | Hitachi, Ltd. | Mass spectrometry and mass spectrometry system |
Also Published As
| Publication number | Publication date |
|---|---|
| US20020076739A1 (en) | 2002-06-20 |
| US6670194B1 (en) | 2003-12-30 |
| EP1329513A1 (en) | 2003-07-23 |
| JP3793124B2 (ja) | 2006-07-05 |
| AU755334C (en) | 2004-02-26 |
| ATE536422T1 (de) | 2011-12-15 |
| EP1105517A4 (en) | 2001-09-19 |
| JP2006184290A (ja) | 2006-07-13 |
| EP1105517A1 (en) | 2001-06-13 |
| EP1105517B2 (en) | 2009-09-30 |
| US7544518B2 (en) | 2009-06-09 |
| WO2000011208A1 (en) | 2000-03-02 |
| EP1105517B1 (en) | 2003-10-29 |
| US6852544B2 (en) | 2005-02-08 |
| ATE253126T1 (de) | 2003-11-15 |
| AU5691399A (en) | 2000-03-14 |
| AU755334B2 (en) | 2002-12-12 |
| DE69912444D1 (de) | 2003-12-04 |
| US20050233399A1 (en) | 2005-10-20 |
| US20030087322A9 (en) | 2003-05-08 |
| EP1329513B1 (en) | 2011-12-07 |
| JP4117320B2 (ja) | 2008-07-16 |
| JP2003107066A (ja) | 2003-04-09 |
| DE69912444T2 (de) | 2004-07-22 |
| JP2002523058A (ja) | 2002-07-30 |
| DE69912444T3 (de) | 2010-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3345401B2 (ja) | 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析 | |
| US7052915B2 (en) | Selective labeling and isolation of phosphopeptides and applications to proteome analysis | |
| EP1311858B1 (en) | Affinity selected signature peptides for protein identification and quantification | |
| AU2003249692B2 (en) | Methods for quantitative proteome analysis of glycoproteins | |
| EP1456632B1 (en) | Methods for isolating and labeling sample molecules | |
| US7449170B2 (en) | Materials and methods for controlling isotope effects during fractionation of analytes | |
| WO2008056290A9 (en) | Use of arylboronic acids in protein labelling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20020815 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 3345401 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080830 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090830 Year of fee payment: 7 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100830 Year of fee payment: 8 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110830 Year of fee payment: 9 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110830 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120830 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120830 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130830 Year of fee payment: 11 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |